Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05119179 · ClinicalTrials.gov registry record · Phase 4
Pharmacogenetics of the Response to GLP-1 in Mexican-Americans With Prediabetes
A Phase 4 study of PreDiabetes, sponsored by The University of Texas Health Science Center, Houston.
- Recruiting
- Registry status
- Phase 4
- Development phase
- 300
- Enrollment target
- 1
- Study location
NCT05119179 is a Phase 4 study of PreDiabetes that is actively recruiting participants, run by The University of Texas Health Science Center, Houston. The registered enrollment target is 300 participants, below the 688-participant average among 89 other PreDiabetes trials with a reported enrollment target (56% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05119179, a Phase 4 study of PreDiabetes, is actively recruiting participants, sponsored by The University of Texas Health Science Center, Houston.
- RECRUITING
- Registry status
- Phase 4
- Development phase
- 300 participants
- Enrollment target
- 1
- Study location
Study Summary
This project uses both transcriptomic- and genomic-level data to identify mechanisms of individual responses to glucagon-like peptide-1 (GLP-1) in Mexican-Americans with prediabetes. The GLP-1 hormone is essential for glucose reduction, weight loss, cardiovascular risk reduction, and renal protection. Newly discovered mechanisms will illuminate causal links between disease genotype and phenotype, which may ultimately guide personalized therapeutic approaches for type 2 diabetes, prediabetes, obesity, cardiovascular disease, renal disease, and other related diseases.
Conditions Studied
Interventions
- DRUG Semaglutide
Study Locations (1)
Texas
- UTHealth Clinical Research Unit (CRU) at UT Brownsville - Brownsville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300 participants |
| Start Date | 2021-11-22 |
| Est. Completion | 2026-10-31 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05119179
The ClinicalTrials.gov registry entry for NCT05119179 describes a study currently listed as recruiting, categorized as Phase 4. The registered enrollment target is 300 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 688-participant average among 89 other PreDiabetes trials with a reported enrollment target (56% lower). The listed sponsor is The University of Texas Health Science Center, Houston, which has 732 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with PreDiabetes appearing as the primary indexed condition, and to 1 intervention - of which Semaglutide is the first listed.
NCT05119179 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT05119179 about?
NCT05119179 is a clinical study titled "Pharmacogenetics of the Response to GLP-1 in Mexican-Americans With Prediabetes". This project uses both transcriptomic- and genomic-level data to identify mechanisms of individual responses to glucagon-like peptide-1 (GLP-1) in Mexican-Americans with prediabetes. The GLP-1 hormone is essential for glucose reduction, weight loss, cardiovascular risk reduction, and renal protectio...
What is the current status of trial NCT05119179?
This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 300 participants. The study started on 2021-11-22. Estimated completion is 2026-10-31.
What conditions does trial NCT05119179 study?
This clinical trial studies the following conditions: PreDiabetes.
What interventions are being tested in trial NCT05119179?
The interventions under investigation include: Semaglutide (DRUG).
Who is sponsoring clinical trial NCT05119179?
This trial is sponsored by The University of Texas Health Science Center, Houston, which has 732 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05119179 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for PreDiabetes
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
The Renin-Angiotensin-Aldosterone System in Adiposity, Blood Pressure and Glucose in African Americans
ACTIVE NOT RECRUITING · Phase 4
-
Use of Empagliflozin to Treat Prediabetes
ACTIVE NOT RECRUITING · Phase 4
-
The Role of Islet GLP-1 in the Pathogenesis of Prediabetes
RECRUITING · Phase 2
-
Longitudinal Multi-Omic Profiles to Reveal Mechanisms of Obesity-Mediated Insulin Resistance
RECRUITING · NA
-
Black Impact: The Mechanisms Underlying Psychosocial Stress Reduction in a Cardiovascular Health Intervention
RECRUITING · NA
-
Diabetes Clinical Decision Support
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.